Cargando…
Development of a PCR Assay to Detect Low Level Trypanosoma cruzi in Blood Specimens Collected with PAXgene Blood DNA Tubes for Clinical Trials Treating Chagas Disease
Chagas disease is caused by the parasitic infection of Trypanosoma cruzi (T. cruzi). The STOP CHAGAS clinical trial was initiated in 2011 to evaluate posaconazole in treating Chagas disease, with treatment success defined as negative qualitative PCR results of detecting the parasites in blood specim...
Autores principales: | Wei, Bo, Chen, Lei, Kibukawa, Miho, Kang, John, Waskin, Hetty, Marton, Matthew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5131911/ https://www.ncbi.nlm.nih.gov/pubmed/27906977 http://dx.doi.org/10.1371/journal.pntd.0005146 |
Ejemplares similares
-
International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients
por: Schijman, Alejandro G., et al.
Publicado: (2011) -
Detection of Trypanosoma cruzi by PCR in adults with chronic Chagas disease treated with nifurtimox
por: Vergara, Camilo, et al.
Publicado: (2019) -
Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023) -
Performance of Chimeric Trypanosoma cruzi Antigens in Serological Screening for Chagas Disease in Blood Banks
por: dos Santos, Emily Ferreira, et al.
Publicado: (2022) -
Optimization of DNA Extraction from Field-Collected Mammalian Whole Blood on Filter Paper for Trypanosoma cruzi (Chagas Disease) Detection
por: Gulas-Wroblewski, Bonnie E., et al.
Publicado: (2021)